Related Experiment Video
Updated: Aug 24, 2026

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
Hyperthyroidism six years post-BMT for acute myeloblastic leukemia in a patient on long-term lithium therapy for
Angeline Law1, Joshua Rifkind, Fred Rosen
1Division of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, ON, Canada.
Abstract:
Lithium is commonly used to treat bipolar affective disorder. It is well known to adversely affect thyroid function, most commonly causing hypothyroidism. Hyperthyroidism is a rare complication. Similarly, total body irradiation (TBI) associated with BMT is well known to affect thyroid function frequently causing hypothyroidism. Hyperthyroidism secondary to TBI is unusual. To have both a history of chronic lithium therapy and TBI with a BMT in patient presenting with hyperthyroidism is an extremely atypical situation. We describe a 39-year-old male who presented with primary hyperthyroidism after 18 years of lithium use for bipolar affective disorder and 6 years post-BMT for AML-M4.